Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Marzo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|March 27, 2001
Preferential localization of effector memory cells in nonlymphoid tissueD Masopust, V Vezys, A L Marzo, et al.
Cancer Research|March 10, 1999
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumorsA L Marzo, R A Lake, B W Robinson, et al.
Cancer Research|August 1, 1997
Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivoA L Marzo, D R Fitzpatrick, B W Robinson, et al.
Clinical and Experimental Immunology|April 1, 1986
Susceptibility to murine experimental autoallergic myasthenia gravis: the role of antibody specificityA L Marzo, M J Garlepp, M Schon-Hegrad, et al.
Immunology and Cell Biology|November 26, 1999
Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulationB W Robinson, R A Lake, D J Nelson, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1995
Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapyH Bielefeldt-Ohmann, A L Marzo, R P Himbeck, et al.
Growth Factors (Chur, Switzerland)|January 1, 1994
Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesotheliomaD R Fitzpatrick, H Bielefeldt-Ohmann, R P Himbeck, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1995
Potential for interferon-alpha-based therapy in mesothelioma: assessment in a murine modelH Bielefeldt-Ohmann, D R Fitzpatrick, A L Marzo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
Tumor antigens are constitutively presented in the draining lymph nodesA L Marzo, R A Lake, D Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor toleranceB W Robinson, B M Scott, R A Lake, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|March 27, 2001
Preferential localization of effector memory cells in nonlymphoid tissueD Masopust, V Vezys, A L Marzo, et al.
Cancer Research|March 10, 1999
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumorsA L Marzo, R A Lake, B W Robinson, et al.
Cancer Research|August 1, 1997
Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivoA L Marzo, D R Fitzpatrick, B W Robinson, et al.
Clinical and Experimental Immunology|April 1, 1986
Susceptibility to murine experimental autoallergic myasthenia gravis: the role of antibody specificityA L Marzo, M J Garlepp, M Schon-Hegrad, et al.
Immunology and Cell Biology|November 26, 1999
Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulationB W Robinson, R A Lake, D J Nelson, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1995
Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapyH Bielefeldt-Ohmann, A L Marzo, R P Himbeck, et al.
Growth Factors (Chur, Switzerland)|January 1, 1994
Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesotheliomaD R Fitzpatrick, H Bielefeldt-Ohmann, R P Himbeck, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1995
Potential for interferon-alpha-based therapy in mesothelioma: assessment in a murine modelH Bielefeldt-Ohmann, D R Fitzpatrick, A L Marzo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
Tumor antigens are constitutively presented in the draining lymph nodesA L Marzo, R A Lake, D Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor toleranceB W Robinson, B M Scott, R A Lake, et al.
Pageof 2